The mode of circumferential margin involvement in rectal cancer determines its impact on outcomes: A population-based study.

Circumferential resection margin Local recurrence Quality of surgery Rectal cancer

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 29 01 2024
revised: 30 06 2024
accepted: 09 08 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 18 8 2024
Statut: aheadofprint

Résumé

The clinical value of different modes of CRM involvement in rectal cancer patients is unclear. This study aims to determine the clinical impact of different modes of circumferential resection margin (CRM) involvement in patients with a locally advanced rectal carcinoma. A cohort of patients who were diagnosed with stage III rectal cancer between June 2014 and June 2020 was selected from the prospective Dutch nationwide pathology databank (PALGA). Histopathological and clinical data were analyzed according to the nature of CRM involvement (via primary tumor invasion, lymph node metastasis, tumor deposit, multiple factors) and analyses on recurrence and overall survival (OS) were performed. 3020 patients were included, of whom 12.4 % had a positive CRM. The majority of these patients (63.2 %) had CRM involvement by primary tumor invasion and in 9 % of patients multiple factors caused the positive CRM. The rates of local recurrence and distant metastasis were related to the nature of the CRM involvement, with lowest rate for lymph node metastasis and highest rate for multiple factors. On multivariate analysis, CRM involvement by primary tumor invasion, tumor deposits and multiple factors, but not by lymph node metastasis, were associated with poor OS. This nationwide population based study highlights the clinical importance of reporting the nature of CRM involvement in rectal cancer patients. Lymph node metastasis involving the CRM does not bear the same risks for local recurrence, distant metastases and OS as CRM involvement by primary tumor invasion or CRM involvement by multiple factors.

Sections du résumé

BACKGROUND BACKGROUND
The clinical value of different modes of CRM involvement in rectal cancer patients is unclear. This study aims to determine the clinical impact of different modes of circumferential resection margin (CRM) involvement in patients with a locally advanced rectal carcinoma.
PATIENTS AND METHODS METHODS
A cohort of patients who were diagnosed with stage III rectal cancer between June 2014 and June 2020 was selected from the prospective Dutch nationwide pathology databank (PALGA). Histopathological and clinical data were analyzed according to the nature of CRM involvement (via primary tumor invasion, lymph node metastasis, tumor deposit, multiple factors) and analyses on recurrence and overall survival (OS) were performed.
RESULTS RESULTS
3020 patients were included, of whom 12.4 % had a positive CRM. The majority of these patients (63.2 %) had CRM involvement by primary tumor invasion and in 9 % of patients multiple factors caused the positive CRM. The rates of local recurrence and distant metastasis were related to the nature of the CRM involvement, with lowest rate for lymph node metastasis and highest rate for multiple factors. On multivariate analysis, CRM involvement by primary tumor invasion, tumor deposits and multiple factors, but not by lymph node metastasis, were associated with poor OS.
CONCLUSION CONCLUSIONS
This nationwide population based study highlights the clinical importance of reporting the nature of CRM involvement in rectal cancer patients. Lymph node metastasis involving the CRM does not bear the same risks for local recurrence, distant metastases and OS as CRM involvement by primary tumor invasion or CRM involvement by multiple factors.

Identifiants

pubmed: 39154428
pii: S0748-7983(24)00650-4
doi: 10.1016/j.ejso.2024.108598
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108598

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Niek Hugen (N)

Rijnstate, Department of Surgery, Arnhem, the Netherlands; Radboud University Medical Center, Department of Surgery, Nijmegen, the Netherlands. Electronic address: Niek.Hugen@radboudumc.nl.

Quirinus J M Voorham (QJM)

PALGA Foundation, Houten, the Netherlands.

Geerard L Beets (GL)

Netherlands Cancer Institute, Department of Surgery, Amsterdam, the Netherlands.

Maurice B Loughrey (MB)

Royal Victoria Hospital, Belfast Health and Social Care Trust, Department of Cellular Pathology, Belfast, UK; Queen's University Belfast, Belfast, UK.

Petur Snaebjornsson (P)

Netherlands Cancer Institute, Department of Pathology, Amsterdam, the Netherlands; University of Iceland, Faculty of Medicine, Reykjavik, Iceland.

Iris D Nagtegaal (ID)

Radboud University Medical Center, Department of Pathology, Nijmegen, the Netherlands.

Classifications MeSH